These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29907221)

  • 21. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
    Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer.
    Murphy CC; Harlan LC; Warren JL; Geiger AM
    J Clin Oncol; 2015 Aug; 33(23):2530-6. PubMed ID: 26150445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
    Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
    Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
    Al-Husseini MJ; Saad AM; Jazieh KA; Elmatboly AM; Rachid A; Gad MM; Ruhban IA; Hilal T
    Int J Colorectal Dis; 2019 Feb; 34(2):285-292. PubMed ID: 30443675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.
    Huang CM; Huang MY; Ma CJ; Yeh Y-; Tsai HL; Huang CW; Huang CJ; Wang JY
    Radiat Oncol; 2017 Mar; 12(1):48. PubMed ID: 28270172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of advanced gallbladder cancer: A SEER-based study.
    Mao W; Deng F; Wang D; Gao L; Shi X
    Cancer Med; 2020 Jan; 9(1):141-150. PubMed ID: 31721465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics Associated With Nonreceipt of Surveillance Testing and the Relationship With Survival in Stage II and III Colon Cancer.
    Hines RB; Jiban MJH; Lee E; Odahowski CL; Wallace AS; Adams SJE; Rahman SMM; Zhang S
    Am J Epidemiol; 2021 Feb; 190(2):239-250. PubMed ID: 32902633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer.
    Arredondo J; Pastor C; Baixauli J; Rodríguez J; González I; Vigil C; Chopitea A; Hernández-Lizoáin JL
    Colorectal Dis; 2013 May; 15(5):552-7. PubMed ID: 23398577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.
    Penn DC; Chang Y; Meyer AM; DeFilippo Mack C; Sanoff HK; Stitzenberg KB; Carpenter WR
    Cancer; 2015 Jan; 121(1):93-101. PubMed ID: 25209056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit.
    Ganapathi AM; Speicher PJ; Englum BR; Castleberry AW; Migaly J; Hsu DS; Mantyh CR
    Dis Colon Rectum; 2014 Dec; 57(12):1341-8. PubMed ID: 25379998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
    Hanna NN; Onukwugha E; Choti MA; Davidoff AJ; Zuckerman IH; Hsu VD; Mullins CD
    Colorectal Dis; 2012 Jan; 14(1):48-55. PubMed ID: 21689262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009.
    Yeboa DN; Xu X; Jones BA; Soulos P; Gross C; Yu JB
    Am J Clin Oncol; 2016 Dec; 39(6):568-574. PubMed ID: 24879475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
    Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
    Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
    BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
    Hsiao FY; Mullins CD; Onukwugha E; Pandya N; Hanna N
    J Am Geriatr Soc; 2011 Sep; 59(9):1717-23. PubMed ID: 21831168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eligibility of Real-World Patients With Stage II and III Colon Cancer for Adjuvant Chemotherapy Trials.
    Batra A; Kong S; Cheung WY
    Clin Colorectal Cancer; 2020 Dec; 19(4):e226-e234. PubMed ID: 32636076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial.
    Yeh YS; Tsai HL; Huang CW; Wei PL; Sung YC; Tang HC; Wang JY
    Trials; 2017 Apr; 18(1):191. PubMed ID: 28441966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.